Literature DB >> 28671338

Mixture model analysis identifies irritable bowel syndrome subgroups characterised by specific profiles of gastrointestinal, extraintestinal somatic and psychological symptoms.

A Polster1, L Van Oudenhove2, M Jones3, L Öhman4, H Törnblom1, M Simrén1,5.   

Abstract

BACKGROUND: Current subgrouping of Irritable Bowel Syndrome (IBS) is exclusively based on stool consistency without considering other relevant gastrointestinal (GI), extraintestinal somatic or psychological features. AIM: To identify subgroups based on a comprehensive set of IBS-related parameters.
METHODS: Mixture model analysis was used, with the following input variables: 13 single-item scores from the IBS-specific Gastrointestinal Symptom Rating Scale, average stool consistency and frequency from a 7-day Bristol Stool Form diary, 12 single-item extraintestinal symptom scores from the Patient Health Questionnaire-12, and anxiety and depression subscale scores from the Hospital Anxiety and Depression scale. The resulting latent subgroups were compared regarding symptom profiles using analysis of variance followed by pair-wise comparisons.
RESULTS: One hundred and seventy-two IBS patients (Rome III; 69% female; mean age 33.7 [range 18-60] years) were included. The optimal subgrouping showed six latent groups, characterised by: (I) constipation with low comorbidities, (II) constipation with high comorbidities, (III) diarrhoea with low comorbidities, (IV) diarrhoea and pain with high comorbidities, (V) mixed GI symptoms with high comorbidities, (VI) a mix of symptoms with overall mild severity. The subgroups showed differences in the distribution of Rome III-subtypes, IBS severity, presence of anxiety and depression, and gender, but not regarding age, IBS duration or reported post-infectious onset of IBS.
CONCLUSIONS: This model-based subgrouping of IBS partly supports the distinction of subgroups based on bowel habits, but additionally distinguishes subgroups with or without co-morbid extraintestinal somatic and psychological symptoms. The resulting groups show specific profiles of symptom combinations.
© 2017 John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2017        PMID: 28671338     DOI: 10.1111/apt.14207

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  5 in total

1.  Effects of a comprehensive self-management intervention on extraintestinal symptoms among patients with IBS.

Authors:  Kendra J Kamp; Kristen R Weaver; LeeAnne B Sherwin; Pamela Barney; Sun-Kyung Hwang; Pei-Lin Yang; Robert L Burr; Kevin C Cain; Margaret M Heitkemper
Journal:  J Psychosom Res       Date:  2019-08-29       Impact factor: 3.006

2.  Associations among neurophysiology measures in irritable bowel syndrome (IBS) and their relevance for IBS symptoms.

Authors:  Irina Midenfjord; Annikka Polster; Henrik Sjövall; Peter Friberg; Hans Törnblom; Magnus Simrén
Journal:  Sci Rep       Date:  2020-06-17       Impact factor: 4.379

3.  Postprandial Symptoms in Patients With Functional Dyspepsia and Irritable Bowel Syndrome: Relations to Ultrasound Measurements and Psychological Factors.

Authors:  Elisabeth K Steinsvik; Jørgen Valeur; Trygve Hausken; Odd H Gilja
Journal:  J Neurogastroenterol Motil       Date:  2020-01-30       Impact factor: 4.924

4.  The Role of Chronic Stress in Normal Visceroception: Insights From an Experimental Visceral Pain Study in Healthy Volunteers.

Authors:  Adriane Icenhour; Franziska Labrenz; Till Roderigo; Sven Benson; Sigrid Elsenbruch
Journal:  Front Psychiatry       Date:  2020-03-03       Impact factor: 4.157

5.  Altered Structural Covariance of Insula, Cerebellum and Prefrontal Cortex Is Associated with Somatic Symptom Levels in Irritable Bowel Syndrome (IBS).

Authors:  Cecilia Grinsvall; Lukas Van Oudenhove; Patrick Dupont; Hyo Jin Ryu; Maria Ljungberg; Jennifer S Labus; Hans Törnblom; Emeran A Mayer; Magnus Simrén
Journal:  Brain Sci       Date:  2021-11-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.